KemPharm, Inc. Reports Third Quarter 2018 Results
KemPharm, Inc. (KMPH)
Last kempharm, inc. earnings: 2/28 07:30 am
Check Earnings Report
US:NASDAQ Investor Relations:
investors.kempharm.com/investor-overview
Company Research
Source: GlobeNewswire
Conference Call and Live Audio Webcast with Slide Presentation Scheduled for Today at 4:30 p.m. ET Development Highlights: Announced positive topline results from KP415.E01 efficacy and safety trial in children with attention deficit hyperactivity disorder (ADHD)Announced positive topline results from the oral and intranasal human abuse potential (HAP) trials of KP415 Prodrug; completed KP415 HAP clinical programPresented data from the intranasal and intravenous HAP trials of KP415 Prodrug at the American Academy of Child & Adolescent Psychiatry meeting Corporate Highlights Entered into a collaboration and license agreement with KVK Tech, Inc. for the commercialization of APADAZ® in the U.S.Announced technology collaboration with twoXAR, Inc. to develop prodrug-based therapies for multiple indicationsHosted KOL investor event focused on the ADHD treatment landscape Financial Highlights: Net loss of $0.94 per basic and diluted share for the quarter ended September 30, 2018, compa
Show less
Read more
Impact Snapshot
Event Time:
KMPH
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
KMPH alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
KMPH alerts
High impacting KemPharm, Inc. news events
Weekly update
A roundup of the hottest topics